Neurodegeneration in Alzheimer’s, Parkinson’s and Related Disorders

Venue: Hyatt Regency Hotel

Location: Princeton, New Jersey, United States

Event Date/Time: Jun 24, 2002 End Date/Time: Jun 25, 2002
Report as Spam

Description

PRESENTING:

ALBERT EINSTEIN COLLEGE OF MEDICINE
AVENTIS
AVENTIS PHARMA FRANCE
BAYER CORPORATION
CEREGENE
CORTEX PHARMACEUTICALS
ELEGENE AG
ELI LILLY & COMPANY
GUILFORD PHARMACEUTICALS
IMMUSOL
MEDICAL COLLEGE OF GEORGIA
MERCK RESEARCH LABORATORIES
MITOKOR INC.
MOUNT SINAI SCHOOL OF MEDICINE
NEUROCHEM, INC.
NEUROGENETICS
NORTHWESTERN UNIVERSITY SCHOOL OF MEDICINE
NYU MEDICAL CENTER -- NATHAN KLINE INSTITUTE
WYETH PHARMACEUTICALS
UNIVERSITY OF SOUTH FLORIDA


ORGANIZED INTO FIVE SECTIONS:

Drug Candidates & Novel Targets
Vaccination & Sequestration
Prevention of Plaque Formation & Deposition
Pathophysiology of Alzheimer's Disease
Parkinson's Disease
Ischemic Stroke & MS



FEATURING:

Passive Immunization with Anti - Abeta Antibodies in a Mouse Model of Alzheimer's Disease : Diagnostic and Therapeutic Implications
ELI LILLY & COMPANY

Modulation of Amyloid Deposition and Learning in an APP+PS1 Transgenic Mouse by Aß Vaccination and a Nitro-NSAID
UNIVERSITY OF SOUTH FLORIDA

Repinotan: A Putative Neuroprotective Compound in Acute Ischaemic Stroke
BAYER CORPORATION

Robust, Chronic Reduction in Amyloid Burden in Brains of PDAPP Mice Treated Orally with a Potent Functional g-Secretase Inhibitor
ELI LILLY & COMPANY

Venue